HEADER TRANSCRIPTION 31-OCT-16 5M96
TITLE SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW TRIAZOLO AND
TITLE 2 IMIDAZOLOPYRIDINE RORGT INVERSE AGONISTS
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: C-TERMINAL DOMAIN, LIGAND BINDING DOMAIN, UNP RESIDUES 263-
COMPND 5 491;
COMPND 6 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1
COMPND 7 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED
COMPND 8 ORPHAN RECEPTOR-GAMMA;
COMPND 9 ENGINEERED: YES;
COMPND 10 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693;
SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID
KEYWDS NUCLEAR HORMONE RECEPTOR, LIGAND-BINDING DOMAIN, INVERSE AGONIST,
KEYWDS 2 TRANSCRIPTION
EXPDTA X-RAY DIFFRACTION
AUTHOR J.KALLEN
REVDAT 4 08-MAY-24 5M96 1 REMARK
REVDAT 3 19-DEC-18 5M96 1 REMARK LINK SITE ATOM
REVDAT 2 28-DEC-16 5M96 1 JRNL
REVDAT 1 14-DEC-16 5M96 0
JRNL AUTH S.HINTERMANN,C.GUNTERMANN,H.MATTES,D.A.CARCACHE,J.WAGNER,
JRNL AUTH 2 A.VULPETTI,A.BILLICH,J.DAWSON,K.KAUPMANN,J.KALLEN,
JRNL AUTH 3 R.STRINGER,D.ORAIN
JRNL TITL SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW TRIAZOLO- AND
JRNL TITL 2 IMIDAZOLOPYRIDINE ROR GAMMA T INVERSE AGONISTS.
JRNL REF CHEMMEDCHEM V. 11 2640 2016
JRNL REFN ESSN 1860-7187
JRNL PMID 27902884
JRNL DOI 10.1002/CMDC.201600500
REMARK 2
REMARK 2 RESOLUTION. 1.77 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.77
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.28
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9
REMARK 3 NUMBER OF REFLECTIONS : 60571
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.193
REMARK 3 R VALUE (WORKING SET) : 0.192
REMARK 3 FREE R VALUE : 0.208
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 3187
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3662
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 140
REMARK 3 SOLVENT ATOMS : 349
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 34.60
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.53
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.00000
REMARK 3 B22 (A**2) : 0.00000
REMARK 3 B33 (A**2) : -0.01000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.108
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.099
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.066
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.062
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA
REMARK 3 BOND LENGTH (A) : NULL ; NULL
REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL
REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL
REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL
REMARK 3
REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL
REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL
REMARK 3
REMARK 3 NON-BONDED CONTACT RESTRAINTS.
REMARK 3 SINGLE TORSION (A) : NULL ; NULL
REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL
REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL
REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL
REMARK 3
REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS.
REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL
REMARK 3 PLANAR (DEGREES) : NULL ; NULL
REMARK 3 STAGGERED (DEGREES) : NULL ; NULL
REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN
REMARK 3 THE INPUT U VALUES : REFINED INDIVIDUALLY
REMARK 4
REMARK 4 5M96 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 31-OCT-16.
REMARK 100 THE DEPOSITION ID IS D_1200002115.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 12-DEC-15
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 7.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SLS
REMARK 200 BEAMLINE : X10SA
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.00003
REMARK 200 MONOCHROMATOR : SI 111 CHANNEL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XSCALE
REMARK 200 DATA SCALING SOFTWARE : XSCALE, XSCALE
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 63761
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.770
REMARK 200 RESOLUTION RANGE LOW (A) : 19.870
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9
REMARK 200 DATA REDUNDANCY : 10.20
REMARK 200 R MERGE (I) : 0.05300
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 26.3000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.77
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.82
REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0
REMARK 200 DATA REDUNDANCY IN SHELL : 10.20
REMARK 200 R MERGE FOR SHELL (I) : 0.90300
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.800
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 60.52
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.12
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 1.75M NAFORMATE, 0.1M PIPES, PH 7.0,
REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z+1/3
REMARK 290 3555 -X+Y,-X,Z+2/3
REMARK 290 4555 -X,-Y,Z+1/2
REMARK 290 5555 Y,-X+Y,Z+5/6
REMARK 290 6555 X-Y,X,Z+1/6
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.56200
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 77.12400
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 57.84300
REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 96.40500
REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 19.28100
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 262
REMARK 465 PRO A 263
REMARK 465 TYR A 264
REMARK 465 HIS A 490
REMARK 465 PRO A 491
REMARK 465 GLY B 262
REMARK 465 PRO B 263
REMARK 465 TYR B 264
REMARK 465 HIS B 488
REMARK 465 LEU B 489
REMARK 465 HIS B 490
REMARK 465 PRO B 491
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 GLU A 435 62.65 -115.30
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue Q6Y A 501
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue Q6Y A 502
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue Q6Y B 501
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue Q6Y B 502
DBREF 5M96 A 263 491 UNP P51449 RORG_HUMAN 263 491
DBREF 5M96 B 263 491 UNP P51449 RORG_HUMAN 263 491
SEQADV 5M96 GLY A 262 UNP P51449 EXPRESSION TAG
SEQADV 5M96 SER A 455 UNP P51449 CYS 455 ENGINEERED MUTATION
SEQADV 5M96 GLY B 262 UNP P51449 EXPRESSION TAG
SEQADV 5M96 SER B 455 UNP P51449 CYS 455 ENGINEERED MUTATION
SEQRES 1 A 230 GLY PRO TYR ALA SER LEU THR GLU ILE GLU HIS LEU VAL
SEQRES 2 A 230 GLN SER VAL CYS LYS SER TYR ARG GLU THR CYS GLN LEU
SEQRES 3 A 230 ARG LEU GLU ASP LEU LEU ARG GLN ARG SER ASN ILE PHE
SEQRES 4 A 230 SER ARG GLU GLU VAL THR GLY TYR GLN ARG LYS SER MET
SEQRES 5 A 230 TRP GLU MET TRP GLU ARG CYS ALA HIS HIS LEU THR GLU
SEQRES 6 A 230 ALA ILE GLN TYR VAL VAL GLU PHE ALA LYS ARG LEU SER
SEQRES 7 A 230 GLY PHE MET GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU
SEQRES 8 A 230 LEU LYS ALA GLY ALA MET GLU VAL VAL LEU VAL ARG MET
SEQRES 9 A 230 CYS ARG ALA TYR ASN ALA ASP ASN ARG THR VAL PHE PHE
SEQRES 10 A 230 GLU GLY LYS TYR GLY GLY MET GLU LEU PHE ARG ALA LEU
SEQRES 11 A 230 GLY CYS SER GLU LEU ILE SER SER ILE PHE ASP PHE SER
SEQRES 12 A 230 HIS SER LEU SER ALA LEU HIS PHE SER GLU ASP GLU ILE
SEQRES 13 A 230 ALA LEU TYR THR ALA LEU VAL LEU ILE ASN ALA HIS ARG
SEQRES 14 A 230 PRO GLY LEU GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN
SEQRES 15 A 230 TYR ASN LEU GLU LEU ALA PHE HIS HIS HIS LEU SER LYS
SEQRES 16 A 230 THR HIS ARG GLN SER ILE LEU ALA LYS LEU PRO PRO LYS
SEQRES 17 A 230 GLY LYS LEU ARG SER LEU CYS SER GLN HIS VAL GLU ARG
SEQRES 18 A 230 LEU GLN ILE PHE GLN HIS LEU HIS PRO
SEQRES 1 B 230 GLY PRO TYR ALA SER LEU THR GLU ILE GLU HIS LEU VAL
SEQRES 2 B 230 GLN SER VAL CYS LYS SER TYR ARG GLU THR CYS GLN LEU
SEQRES 3 B 230 ARG LEU GLU ASP LEU LEU ARG GLN ARG SER ASN ILE PHE
SEQRES 4 B 230 SER ARG GLU GLU VAL THR GLY TYR GLN ARG LYS SER MET
SEQRES 5 B 230 TRP GLU MET TRP GLU ARG CYS ALA HIS HIS LEU THR GLU
SEQRES 6 B 230 ALA ILE GLN TYR VAL VAL GLU PHE ALA LYS ARG LEU SER
SEQRES 7 B 230 GLY PHE MET GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU
SEQRES 8 B 230 LEU LYS ALA GLY ALA MET GLU VAL VAL LEU VAL ARG MET
SEQRES 9 B 230 CYS ARG ALA TYR ASN ALA ASP ASN ARG THR VAL PHE PHE
SEQRES 10 B 230 GLU GLY LYS TYR GLY GLY MET GLU LEU PHE ARG ALA LEU
SEQRES 11 B 230 GLY CYS SER GLU LEU ILE SER SER ILE PHE ASP PHE SER
SEQRES 12 B 230 HIS SER LEU SER ALA LEU HIS PHE SER GLU ASP GLU ILE
SEQRES 13 B 230 ALA LEU TYR THR ALA LEU VAL LEU ILE ASN ALA HIS ARG
SEQRES 14 B 230 PRO GLY LEU GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN
SEQRES 15 B 230 TYR ASN LEU GLU LEU ALA PHE HIS HIS HIS LEU SER LYS
SEQRES 16 B 230 THR HIS ARG GLN SER ILE LEU ALA LYS LEU PRO PRO LYS
SEQRES 17 B 230 GLY LYS LEU ARG SER LEU CYS SER GLN HIS VAL GLU ARG
SEQRES 18 B 230 LEU GLN ILE PHE GLN HIS LEU HIS PRO
HET Q6Y A 501 35
HET Q6Y A 502 35
HET Q6Y B 501 35
HET Q6Y B 502 35
HETNAM Q6Y ~{N}-[8-[[(3~{S})-4-CYCLOPENTYLCARBONYL-3-METHYL-
HETNAM 2 Q6Y PIPERAZIN-1-YL]METHYL]-7-METHYL-IMIDAZO[1,2-A]PYRIDIN-
HETNAM 3 Q6Y 6-YL]-2-METHYL-PYRIMIDINE-5-CARBOXAMIDE
FORMUL 3 Q6Y 4(C26 H33 N7 O2)
FORMUL 7 HOH *349(H2 O)
HELIX 1 AA1 SER A 266 GLU A 283 1 18
HELIX 2 AA2 ARG A 288 GLN A 295 1 8
HELIX 3 AA3 ARG A 296 ASN A 298 5 3
HELIX 4 AA4 SER A 301 LYS A 311 1 11
HELIX 5 AA5 SER A 312 LEU A 338 1 27
HELIX 6 AA6 GLY A 340 LEU A 344 5 5
HELIX 7 AA7 CYS A 345 MET A 365 1 21
HELIX 8 AA8 GLY A 384 GLY A 392 5 9
HELIX 9 AA9 CYS A 393 ALA A 409 1 17
HELIX 10 AB1 SER A 413 ILE A 426 1 14
HELIX 11 AB2 GLU A 435 THR A 457 1 23
HELIX 12 AB3 ARG A 459 LEU A 466 5 8
HELIX 13 AB4 PRO A 468 LEU A 489 1 22
HELIX 14 AB5 SER B 266 THR B 284 1 19
HELIX 15 AB6 ARG B 288 GLN B 295 1 8
HELIX 16 AB7 ARG B 296 ASN B 298 5 3
HELIX 17 AB8 SER B 301 LYS B 311 1 11
HELIX 18 AB9 SER B 312 ARG B 337 1 26
HELIX 19 AC1 LEU B 338 GLU B 343 1 6
HELIX 20 AC2 CYS B 345 MET B 365 1 21
HELIX 21 AC3 GLY B 384 GLY B 392 5 9
HELIX 22 AC4 CYS B 393 LEU B 410 1 18
HELIX 23 AC5 SER B 413 ILE B 426 1 14
HELIX 24 AC6 GLU B 435 THR B 457 1 23
HELIX 25 AC7 ARG B 459 LEU B 466 5 8
HELIX 26 AC8 GLY B 470 GLN B 487 1 18
SHEET 1 AA1 3 TYR A 369 ASN A 370 0
SHEET 2 AA1 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370
SHEET 3 AA1 3 LYS A 381 GLY A 383 -1 O GLY A 383 N VAL A 376
SHEET 1 AA2 3 TYR B 369 ASN B 370 0
SHEET 2 AA2 3 THR B 375 PHE B 378 -1 O THR B 375 N ASN B 370
SHEET 3 AA2 3 LYS B 381 GLY B 383 -1 O LYS B 381 N PHE B 378
SITE 1 AC1 16 CYS A 320 HIS A 323 LEU A 324 MET A 365
SITE 2 AC1 16 ALA A 368 VAL A 376 PHE A 377 PHE A 378
SITE 3 AC1 16 ILE A 400 PHE A 401 SER A 404 HIS A 479
SITE 4 AC1 16 PHE A 486 HOH A 653 HOH A 708 HOH A 711
SITE 1 AC2 12 THR A 325 ILE A 328 GLN A 329 GLU A 333
SITE 2 AC2 12 LYS A 354 MET A 358 HOH A 657 GLN B 346
SITE 3 AC2 12 ILE B 350 LEU B 353 Q6Y B 502 HOH B 663
SITE 1 AC3 16 CYS B 320 HIS B 323 LEU B 324 MET B 365
SITE 2 AC3 16 ALA B 368 VAL B 376 PHE B 377 LEU B 396
SITE 3 AC3 16 ILE B 397 ILE B 400 PHE B 401 SER B 404
SITE 4 AC3 16 HIS B 479 HOH B 629 HOH B 686 HOH B 689
SITE 1 AC4 11 THR A 325 ILE A 328 GLN A 329 VAL A 332
SITE 2 AC4 11 LEU A 353 Q6Y A 502 HOH A 657 VAL B 332
SITE 3 AC4 11 GLN B 346 ILE B 350 LYS B 354
CRYST1 100.017 100.017 115.686 90.00 90.00 120.00 P 61 12
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.009998 0.005773 0.000000 0.00000
SCALE2 0.000000 0.011545 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008644 0.00000